As a highly differentiated M2-like TAMs subset, bM2-like TAMs may play an anti-tumor role by activating T cells via ALCAM/CD6 interactions, as well as by promoting α-SMA+ myofibroblasts production via TGF-β secretion. The gene discussed is CD6; the disease is neoplasm.